BACKGROUND: Acute macular neuroretinopathy (AMNR) is a rare disease entity, the diagnosis of which is frequently complicated by the subtlety of biomicroscopic findings. METHODS: Two cases of AMNR are presented, in which the diagnosis and follow-up was enabled using the Spectralis HRA+OCT in the absence of clear biomicroscopic findings. RESULTS: The typical lesions were visualized by hyporeflexion during infrared imaging and faded over time. With spectral domain optical coherence tomography, changes in the outer retina in the affected regions were documented, with no change over time. CONCLUSION: The broader availability of this technology may enhance the diagnosis and follow-up of AMNR.
BACKGROUND: Acute macular neuroretinopathy (AMNR) is a rare disease entity, the diagnosis of which is frequently complicated by the subtlety of biomicroscopic findings. METHODS: Two cases of AMNR are presented, in which the diagnosis and follow-up was enabled using the Spectralis HRA+OCT in the absence of clear biomicroscopic findings. RESULTS: The typical lesions were visualized by hyporeflexion during infrared imaging and faded over time. With spectral domain optical coherence tomography, changes in the outer retina in the affected regions were documented, with no change over time. CONCLUSION: The broader availability of this technology may enhance the diagnosis and follow-up of AMNR.
Authors: Giulio Barteselli; Dirk-Uwe Bartsch; Francesco Viola; Francesca Mojana; Marco Pellegrini; Kathrin I Hartmann; Eleonora Benatti; Simon Leicht; Roberto Ratiglia; Giovanni Staurenghi; Robert N Weinreb; William R Freeman Journal: Am J Ophthalmol Date: 2013-06-13 Impact factor: 5.258
Authors: Sun Young Lee; Justine L Cheng; Karen M Gehrs; James C Folk; Elliott H Sohn; Stephen R Russell; Zhihui Guo; Michael D Abràmoff; Ian C Han Journal: JAMA Ophthalmol Date: 2017-11-01 Impact factor: 7.389